Cancer Institute– A national cancer institute
designated cancer center

Billy W. Loo, Jr., MD, PhD, DABR

Back to Profile

Publication Details

  • American College of Chest Physicians and Society of Thoracic Surgeons consensus statement for evaluation and management for high-risk patients with stage I non-small cell lung cancer.

    Donington J, Ferguson M, Mazzone P, Handy J, Schuchert M, Fernando H, Loo B, Lanuti M, de Hoyos A, Detterbeck F, Pennathur A, Howington J, Landreneau R, Silvestri G. Chest. 2012; 142 (6): 1620-35

    The standard treatment of stage I non-small cell lung cancer (NSCLC) is lobectomy with systematic mediastinal lymph node evaluation. Unfortunately, up to 25% of patients with stage I NSCLC are not candidates for lobectomy because of severe medical comorbidity.

    PubMedID: 23208335

Stanford Medicine Resources:

Footer Links: